Table I.
Clinical and demographic characteristics of the patients.
| CBAV (n=30) | TAV (n=30) | P-value | |
|---|---|---|---|
| Age (years) | 61±9 | 59±11 | 0.44 |
| Female (n) | 13 | 11 | 0.60 |
| Risk factors | |||
| Hypertension (n) | 11 | 9 | 0.58 |
| Hypercholesterolemia (n) | 10 | 10 | 1.00 |
| Diabetes mellitus (n) | 4 | 6 | 0.49 |
| Chronic kidney disease (n) | 1 | 0 | 0.31 |
| Smoking (n) | 11 | 14 | 0.43 |
| Medical therapy | |||
| Diuresis (n) | 27 | 29 | 0.30 |
| ARB (n) | 4 | 5 | 0.72 |
| ACEI (n) | 6 | 5 | 0.74 |
| UCG parameters | |||
| LVEF (%) | 52±6 | 54±4 | 0.13 |
| AVA (cm) | 0.88±0.2 | 0.81±0.3 | 0.29 |
| Mean gradient (mmHg) | 55±16 | 59±14 | 0.31 |
| Aortic annulus diameter (cm) | 23±2.3 | 24±1.9 | 0.07 |
CBAV, congenital bicuspid aortic valve; TAV, tricupsid aortic valve; ARB, angiotensin receptor blocker; ACEI, angiotensin-converting enzyme inhibitor; UCG, ultrasound cardiography; LVEF, left ventricular ejection fraction; AVA, aortic valve area.